Correction to: Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection.
修正：瑞士透析人群中與 COVID-19 大流行相關的死亡率超越 SARS-CoV-2 感染。
Clin Kidney J 2025-02-17
Corrigendum to "WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE" [<i>Kidney International Reports</i> Volume 9, Issue 4, Supplement, April 2024, Page S251-S252].
對於「WCN24-813 心衰竭合併慢性腎病患者急性液體過載的管理：使用居家配送的皮下注射 Furosemide」的更正 [<i>Kidney International Reports</i> 第9卷，第4期，補充，2024年4月，頁S251-S252]。
Kidney Int Rep 2024-09-18
看起來你提到的是一篇有特定 DOI 的文章的更正。如果你需要幫助理解這個更正、總結文章內容，或是其他相關的問題，請提供更多細節！
PubMedDOI
Correction to: Reduction in kidney function decline and risk of severe clinical events in agalsidase beta-treated Fabry disease patients: a matched analysis from the Fabry Registry.
修正：在接受 agalsidase beta 治療的 Fabry 病患者中，腎功能下降及嚴重臨床事件風險的減少：來自 Fabry 註冊的匹配分析。
Clin Kidney J 2024-10-18
Corrigendum to "Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes" [J. Clin. Translat. Endoc. 36C (2024) 100343].
對於「Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes」的更正 [J. Clin. Translat. Endoc. 36C (2024) 100343]。
J Clin Transl Endocrinol 2025-01-07
Corrigendum to "Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia" [<i>Kidney International Reports</i> Volume 9, Issue 5, May 2024, Pages 1419-1428].
對於「Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia」的更正 [<i>Kidney International Reports</i> 第9卷，第5期，2024年5月，頁1419-1428]。
Kidney Int Rep 2025-02-24
Corrigendum to "POS-074 SERUM NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN, EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN ASPHYXIATED TERM NEONATES AT LAGOS STATE UNIVERSITY TEACHING HOSPITAL" [<i>Kidney International Reports</i> Volume 7, Issue 2, Supplement, February 2022, Page S31].
對於「POS-074 SERUM NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN, EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN ASPHYXIATED TERM NEONATES AT LAGOS STATE UNIVERSITY TEACHING HOSPITAL」的更正 [<i>Kidney International Reports</i> 第7卷，第2期，補充，2022年2月，第S31頁]。
Kidney Int Rep 2025-02-24
Corrigendum to "Avoid Preanalytical Errors When Using Urine Biomarkers of Exposure" [<i>Kidney International Reports</i> Volume 10, Issue 1, January 2025, Page 281].
對於「避免在使用尿液暴露生物標記時產生前分析錯誤」的更正 [<i>Kidney International Reports</i> 第10卷，第1期，2025年1月，第281頁]。
Kidney Int Rep 2025-04-14
Corrigendum to "Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations" [<i>Kidney International Reports</i> Volume 9, Issue 9, September 2024, Pages 2608-2618].
對於「Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations」的更正 [<i>Kidney International Reports</i> 第9卷，第9期，2024年9月，頁2608-2618]。
Kidney Int Rep 2025-04-14